Hypobaria and Traumatic Pneumothorax
The Effects of Hypobaric Conditions on Small, Traumatic Pneumothoraces
The Effects of Hypobaric Conditions on Small, Traumatic Pneumothoraces
Sponsor study identifier
observational
20
1 country
1
Study Start
October 2012
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
December 2013
Actual (reported)Study Completion
December 2013
Actual (reported)The purpose of this research is to see if people who have had a collapsed lung that has been re-expanded can be safely taken to an elevation that a person might experience while in a commercial airplane without having their lung partially collapse again, or have any symptoms such as feeling short of breath or having oxygen levels in the blood decrease while at the simulated altitude. The investigators hypothesize that subjects who have had a collapsed lung that has been re-expanded will not have any adverse symptoms or signs while subjected to a simulated altitude of 8400 feet (565mm Hg) or 12650 ft (471mm Hg).
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 2013
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
August 18, 2012
Actual (reported)August 23, 2012
Actual (reported)October 2012
Date type not reportedThis date has not been verified as actual or estimated.
December 2013
Actual (reported)December 2013
Actual (reported)Change in pneumothorax size
Will document pneumothorax size before simulated altitude, and size after being at simulated altitude for two hours
baseline and 2 hours
hypobaric chamber
We will use a large (26 tons) multi-place hyperbaric and hypobaric chamber at IMC in Murray, Utah (elevation 1500m or 4500ft, average ambient barometric pressure 645mm Hg). In the hypobaric study, the barometric pressure will be lowered to 554mm Hg (phase 1) or 471mm Hg (phase 2) over 20 minutes and held there for two hours.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Patients with unilateral pneumothorax of traumatic etiology that has been treated with oxygen, observation, or tube thoracostomy
Intermountain Medical Center
Murray, Utah, 84157, United States
Sarah Majercik, MD, MBA
Intermountain Health Care, Inc.
Lindell Weaver, MD
Intermountain Health Care, Inc.
20 participants (actual enrollment reported by the registry).
First Submitted
August 18, 2012
First Posted
August 23, 2012
Study Start
October 2012
Date type not reportedThis date has not been verified as actual or estimated.
Disconnection Technique With a Bronchial Blocker for Improving Lung Deflation
Contact the study team to confirm eligibility.
Primary Completion
December 2013
Actual (reported)Study Completion
December 2013
Actual (reported)Last Updated
April 28, 2014
Record last verified: 2014-04
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: